Long Term Outcomes of a Phase 1/2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of BMN 110 in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome)

Published 2012 View Full Article

Authors

Keywords

Journal

MOLECULAR GENETICS AND METABOLISM

Volume 105, Issue 2, Pages S35

Publisher

Elsevier BV

Online

2012-01-20

DOI

10.1016/j.ymgme.2011.11.076

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

MOLECULAR GENETICS AND METABOLISM

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Become a Peeref-certified reviewer

Ask a Question. Answer a Question.